Dr. Ozga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
810 Jasonway Ave
Ste A
Columbus, OH 43214Phone+1 614-442-3130Fax+1 614-442-3145
Education & Training
Ohio State University HospitalResidency, Internal Medicine, 2018 - 2021
University of Illinois College of MedicineClass of 2018
Certifications & Licensure
OH State Medical License 2018 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 28 citationsAllogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter studySiddharth Kunte, Lisa Rybicki, Auro Viswabandya, Roni Tamari, Asad Bashey
Leukemia. 2021-10-18 - 4 citationsConcomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma.Michael Ozga, Qiuhong Zhao, Laila Huric, Cecelia Miller, Ashley Rosko
Blood Cancer Journal. 2023-11-10 - 11 citationsAL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival.Michael Ozga, Qiuhong Zhao, Don M. Benson, Patrick Elder, Nita Williams
Cancer Medicine. 2021-02-01
Lectures
- AL Amyloidosis: The Effects of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- The Effect of Cytogenetic Abnormalities on Organ Involvement and Survival in Patients with AL Amyloidosis61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
